But take 100 cases by Dec 1. Even assuming a 4.1 day doubling time, you're looking at 7-8 doublings in December. That means 12,800 to 25,600 infections. The WHO-China report reports 168 cases in Wuhan with symptom onset before Dec 31.
3/
Let's assume that 7% of them are hospitalized and therefore ascertained: 896-1792. Way too high.
9 cases by Dec 1: 80-161 onset by Dec 31. A little lower than observed.
26 cases by Dec 1 (our upper bound): 232-465 onset by Dec 21.
Clearly our estimates fall are realistic.
4/
And that is not even taking into account that a zero-mitigation Wuhan likely saw doubling time quicker than 4.1 days.
At any rate, 9 and 26 and 100 are not so different. With only about 7% of this cases ending up in hospital some 2 weeks after infection...
5/
... and only a small fraction, say 7%, ending up in hospital and ascertained, the earliest known patient at Dec 10 (~2 weeks from infection), and 168 patients in Wuhan with onset in December, is fully consistent with a mid to late November origin of the pandemic.
6/
In fact, it is *extremely* unlikely, given how contagious even version 1.0 of this virus was, that the first case could have been before mid to late November, or that there could have been more than 10 to 25 infected patients in November.
7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is work led by @c_drosten and Jan Felix Drexler, and congrats to first author @ana_lenina, and the other co-authors.
Quick background: SARS-CoV-2 is unique among SARSr-CoVs in having a short stretch of basic amino acids in its Spike protein, the FCS,
2/
This motif allows SC2 to infect lung cells and is likely a key to this virus's high transmissability. It is the secret sauce that allowed it to become a pandemic pathogen (along with other features like Spike's ability to bind well to proteins on human cells)
3/
Intemperate attacks? No, @mattwridley, it is not at all intemperate to call you out as I did. It needs to happen more often. Says the purveyor of disinformation, "how DARE you accuse me of spreading disinformation!"
So sad to see you of all people, @RichardDawkins, being taken in by and amplifying the antiscientific misinformation and disinformation put out by @mattwridley regarding the origin of #SARSCoV2. 1/
If you'd be willing to read some of the scientific literature that would put you in a position to assess whether Matt is balanced and fair-minded, here are a 3 recommendations. (Also, I would encourage you to read Matt's tweets on the subject, and see how balanced they are.)
2/
Paper # is a stunning study led by Xiao Xiao and Zhaomin Zhou, with our Oxford Zoology colleagues @WildCRU_Ox. It put the lie to the Chinese delegation's assertion in the WHO-China report that no live, illegal wildlife was sold at Huanan Market. 3/
"Chinese Scientist Hits Back at [my ] Wuhan market coronavirus origin paper"
Dr. Liang Wannian, the lead scientist on the WHO-China study on SC2's origin, has badly misunderstood or misrepresented the science here. Some thoughts in a 🧵, 1/33
What is clear to me from Liang's comments is that the Chinese regime is *deeply* fearful of the strong evidence that places the origin of the pandemic at Huanan Market. But first it is incumbent upon me to acknowledge that he raises one important point. 2/
Although it was a tangential point in my paper in @ScienceMagazine (see below), Liang asserts that the earliest known case *was* a Mr Chen, an accountant with no connection to Huanan Market, with symptom onset of Dec 8, not 16. 3/ science.org/doi/10.1126/sc…
Short 🧵
No, it's not just as risky @ydeigin.
This ridiculous comment captures perfectly a growing concern I have. A much-needed discussion about making pathogen research as safe as possible is getting hijacked by the SARS-CoV-2 origin debate. 1/
People who lack expertise can sometimes make important contributions. But often those with expertise are in a better position to do so.
My daughter is going to have a complicated surgery soon, and I would like her surgeon to decide how to do it as safely as possible. 2/
I am relying on the surgeon's expertise and experience to inform his sense of proportion, something that is lacking in many believers in a lab leak origin of SARS-CoV-2 when it comes to lab safety. 3/
1 of 9: Thank you SO MUCH @profvrr, Kathy Spindler, and @alandove for your excellent discussion of my recent COVID origins Perspective in @ScienceMagazine
2: You hit on key points I wanted people to take home, especially that there really was a preponderance of early COVID cases linked to Huanan Market and this can't be dismissed as ascertainment bias (undue searching for cases linked to the market, while ignoring unlinked cases).
3: This, along with the fact that if the pandemic started there you should *expect* to see some cases unlinked to the market early on as people were infected then moved the virus into the nearby community, points squarely at the market as the overwhelmingly likely site of origin.